ANZUP 2023 | Does every patients with MIBC require a cystectomy?

Dickon Hayne, MBBS, MD, FRCS, FRACS, The University of Western Australia, Perth, Australia, comments on whether all patients with localized bladder cancer, especially muscle-invasive bladder cancer (MIBC), need a cystectomy. Whilst neoadjuvant chemotherapy and surgery is the standard of care in MIBC, trimodal therapy consisting of chemotherapy, radiotherapy and transurethral resection of a bladder tumour (TURBT), as well as quadrimodal therapy with the addition of immunotherapy is gaining traction. Bladder preservation should be the ultimate aim whenever possible. This interview took place at the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group annual scientific meeting in Melbourne, Australia.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.